OVS (OVS) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
24 Jun, 2026Executive summary
Net sales for H1 2024 reached €761.7 million, up 3.6% year-over-year, with both OVS and Upim brands contributing positively and outperforming a flat or slightly negative market despite adverse weather conditions.
Gross margin improved to 59.6% of sales, up 200 basis points from H1 2023, reflecting better purchasing conditions and markdown management.
Adjusted EBITDA rose to €89.0 million (11.7% margin), with net income at €34.6 million, both increasing year-over-year.
UPIM brand led with 7.3% sales growth and 26.5% EBITDA growth, while OVS brand grew 2.5% in sales.
Positive sales momentum continued into August and September, with September showing double-digit growth and year-to-date like-for-like sales exceeding 5%.
Financial highlights
Net sales: €761.7 million (+3.6% YoY); gross margin: 59.6% (+200 bps YoY); EBITDA: €89.0 million (+3.0% YoY); EBIT: €57.3 million (+4.8% YoY); net income: €34.6 million (+2.8% YoY).
EBITDA margin: 11.7%; EBIT margin: 7.5%; net profit margin: 4.5%.
Net debt/adjusted net financial position: €263.0 million, leverage at 1.38x EBITDA (1.09x excluding treasury shares).
Working capital reduced by €11 million year-over-year; inventory in hand 8% lower, but higher stock in transit due to Suez Canal disruptions.
CapEx reached €46.2 million in H1, focused on store refurbishments, logistics automation, and digital transformation.
Outlook and guidance
All brands started H2 2024 with strong sales; August sales up 7% and September double-digit, supporting optimism for Q3 and full-year performance.
Gross margin expected to remain above last year, with a slight decrease in H2 due to dollar effects.
Tax rate for 2024 projected at 25%-26%, with increases due to new international regulations.
Latest events from OVS
- Q3 2024 saw double-digit sales and EBITDA growth, with robust outlook and enhanced shareholder returns.OVS
Q3 20258 Jul 2026 - Record H1 2025 sales and profit growth, led by women's, beauty, and Goldenpoint integration.OVS
Q2 202624 Jun 2026 - Net sales up 12.1% and organic EBITDA up 27.1%, with improved leverage and strong outlook.OVS
Q1 202718 Jun 2026 - Record sales, profit, and cash flow growth drive a 27% dividend hike and strong 2026 outlook.OVS
Q4 202617 Apr 2026 - Q1 sales and margins rose, with strong brand momentum and a positive outlook for 2024.OVS
Q1 20253 Feb 2026 - Sales up 6.2%, margins and cash flow improved, with higher dividend and buyback ahead.OVS
Q4 202523 Dec 2025 - Sales and EBITDA up, leverage improved, and outlook remains positive for year-end.OVS
Q3 202618 Dec 2025 - Q1 sales grew 0.6% to €354.4m; Goldenpoint synergies and Q2 momentum support a positive outlook.OVS
Q1 202614 Nov 2025